ECDC-EMA statement on updating COVID-19 vaccines composition for new SARS-CoV-2 virus variants

ECDC and EMA have issued a joint statement on adapted COVID-19 vaccines and considerations for their use during the upcoming autumn 2023 vaccination campaigns.